 intraves bacillu calmette-guerin patient high-risk superfici bladder cancer intraves bacillu calmette-guerin bcg treatment patient aggress superfici transit cell carcinoma bladder cta cti patient previou histori recurr superfici diseas treatment failur intraves therapi thirty-six patient treatment treatment failur twenty-seven patient tumor patient cti mean follow-up period month diseas progress patient muscl invas diseas patient histori previou event tumor recurr posit urinari cytolog multicentr diseas patient characterist bcg effect agent superfici transit cell carcinoma bladder high-risk group patient previou intraves therapi bcg group patient prior radic surgeri